ELIZABETH VAUGHAN to Cardiovascular Diseases
This is a "connection" page, showing publications ELIZABETH VAUGHAN has written about Cardiovascular Diseases.
Connection Strength
0.952
-
Built Environment and Cardiovascular Diseases - Insights from a Global Review. Curr Atheroscler Rep. 2025 Mar 05; 27(1):36.
Score: 0.095
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2025 Feb 06; 27(1):30.
Score: 0.094
-
Highlights of Cardiovascular Disease Prevention Studies?Presented at the 2024 European Society of Cardiology?Congress. Curr Atheroscler Rep. 2024 Dec 02; 27(1):14.
Score: 0.093
-
Going from Primary to Primordial Prevention: Is the Juice Worth the Squeeze? Curr Cardiol Rep. 2024 Oct; 26(10):1135-1143.
Score: 0.091
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference. Curr Atheroscler Rep. 2024 Aug; 26(8):367-381.
Score: 0.090
-
Global Cardiovascular Research: Gaps and Opportunities. Curr Cardiol Rep. 2023 12; 25(12):1831-1838.
Score: 0.087
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress. Curr Atheroscler Rep. 2023 12; 25(12):965-978.
Score: 0.087
-
Demographic and Regional Trends of Cardiovascular Diseases and Diabetes Mellitus-Related Mortality in the United States From 1999 to 2019. Am J Med. 2023 07; 136(7):659-668.e7.
Score: 0.084
-
A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents? Curr Cardiol Rep. 2022 06; 24(6):689-698.
Score: 0.077
-
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). Am J Cardiol. 2022 06 01; 172:7-10.
Score: 0.077
-
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 02 01; 45(2):372-380.
Score: 0.077